Metal Oxide Semiconductor Nanoparticles Open the Door to New Medical Innovations

Technology available for licensing: novel nanometer-sized metal oxide semiconductors that allow targeting, initiating and control of in vitro and in vivo chemical reactions in biological molecules, such as DNA, proteins, and antibodies.

  • Allows for targeting, initiation and control of in vitro and in vivo chemical reactions in biological molecules
  • Commercial applications include synthetic DNA/RNA endonucleases, gene surgery, targeted cell metabolic intervention and more